http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-105402-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b9f373878f16dc291ff597162e9b344 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate | 1991-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0564fdf6c3b1a192753ae1228a1adc3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1d421e52327d9afa2465a3f0dec62c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d7331e600ca9b8097a3f9c1e91dec5 |
publicationDate | 1994-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | MY-105402-A |
titleOfInvention | 17-beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation. |
abstract | STEROIDIC 5- REDUCTASE INHIBITORS OF FORMULA (I) (FORMULA 1) WHERE R1 IS HYDROGEN, C1- C6 ALKYL, ARYL- C1- C6 ALKYL OR AROYL; Y IS 0 OR S; W IS -N WHEREIN EACH OF R2 AND R3 IS INDEPENDENTLY HYDROGEN, C1- C6 ALKYL, C5- C6 CYCLOALKYL, C6- C9 CYCLOALKYLALKYL AND ARYL WHEREIN EACH OF THE ALKYL, CYCLOALKYL, CYCLOALKYLALKYL AND ARYL GROUPS IS UNSUBSTITUTED OR SUBSTITUTED BY A SUBSTITUENT -OR4 WHERE R4 IS HYDROGEN OR C1- C4 ALKYL; A IS HYDROGEN, C1- C6 ALKYL, C5- C6 CYCLOALKYL OR C6- C9 CYCLOALKYLALKYL WHEREIN EACH OF THE ALKYL, CYCLOALKYL AND CYCLOALKYLALKYL GROUPS IS UNSUBSTITUTED OR SUBSTITUTED BYA SUBSTITUENT: (A) -OR4 AS DEFINED ABOVE OR (B) -N WHEREIN EITHER EACH OF R5 AND R6 IS INDEPENDENTLY HYDROGEN, C1- C6 ALKYL, C5- C6 CYCLOALKYL AND ARYL OR R5 AND R6, TAKEN TOGETHER WITH THE NITROGEN ATOM TO WHICH THEY ARE LINKED, FORM A PENTATOMIC OR HEXATOMIC SATURATED HETEROMONOCYCLIC RING OPTIONALLY CONTAINING AT LEAST ONE ADDITIONAL - O OR S ATOM; AND THE SYMBOL (------) REPRESENTS A SINGLE OR DOUBLE BOND; AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF; ARE USEFUL FOR THE TREATMENT OF ANDROGEN DEPENDENT CONDITIONS. |
priorityDate | 1990-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155 |
Total number of triples: 21.